DFX Intelligence

Data Factory

Private equityFirmbuyoutlower middle market

Boldrose Capital

Private Equity

Greenwich, CT

Rose Capital is a leading investment firm in the emerging legal cannabis sector. We understand the intricacies of public and private investment as well as the challenges and complexity of this explosive market.

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:0be8f43c-fe9c-4ec5-9260-1384622e3874

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 20, 2026, 1:02 PM UTC and rebuilt at most every 15 minutes.

Relationships: 26
Dated events: 34
On other graphs: 2
Observed: Sep 13, 2026 to Sep 17, 2026
27 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Independent Sponsorsidentity

Boldrose Capital

Capital provider to sponsors · shared crd

RIA / Wealth Managementidentity

BOLDROSE CAPITAL

Registered adviser · shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 21
PE funds: 21
Vintages: 2023 to 2024
PE GAV, 2024 filing: $30.3Mgross asset value on Form ADV; never dry powder
Investments: 0
Active investments: 0
Size band: LOWER MIDDLE MARKETderivedproxy: $0.03bn Private Equity Fund GAV on the Form ADV filed 2024-03-28
Stated sectors: distribution,consumer,transportation_logistics
Stated control: control
Latest ADV filing: Mar 28, 2024
Website: rosecapital.com

Funds

Fund	Vintage	Lifecycle	ADV type	Form D sold	GAV
Srg7 LLC	2024	Unknown	Private Equity Fund	n/a	$263,988
Srg5, LLC	2023	Early deployment	Private Equity Fund	n/a	$448,872
Srg6, LLC	2023	Unknown	Private Equity Fund	n/a	$102,766
Rsg1 LLC	n/a	Unknown	Private Equity Fund	n/a	$555,898
Srg2, LLC	n/a	Unknown	Private Equity Fund	n/a	$11.4M
Rsg2 LLC	n/a	Wound down	Private Equity Fund	n/a	$359,646
Srg4 LLC	n/a	Active deployment	Private Equity Fund	n/a	$426,283
Srg1 LLC	n/a	Unknown	Private Equity Fund	n/a	$1.9M
Rsg6 LLC	n/a	Unknown	Private Equity Fund	n/a	$272,873
Rsf2, LLC	n/a	Wound down	Private Equity Fund	n/a	$3.0M
Srj1 LLC	n/a	Wound down	Private Equity Fund	n/a	$340,000
Rsf4 II LLC	n/a	Wound down	Private Equity Fund	n/a	$565,070
Rsf4 LLC	n/a	Wound down	Private Equity Fund	n/a	$2.8M
Rsg4 LLC	n/a	Wound down	Private Equity Fund	n/a	$172,614
Rsg5 LLC	n/a	Wound down	Private Equity Fund	n/a	$154,853
Rsf2 II, LLC	n/a	Wound down	Private Equity Fund	n/a	$8.6M
Rsf5 LLC	n/a	Wound down	Private Equity Fund	n/a	$1.8M
Rsf7 LLC	n/a	Unknown	Private Equity Fund	n/a	$0
Srg3 LLC	n/a	Active deployment	Private Equity Fund	n/a	$988,636
Rose Capital Fund I LP	n/a	Unknown	Private Equity Fund	n/a	$14.0M
Blueridge Holistics LLC	n/a	Unknown	Private Equity Fund	n/a	$201,245

Relationships

Employs (5)

→ Eileen KavanaghPersonChief Financial Officer
Dec 1, 2020 to presentfactForm ADV
→ Andrew Todd SchweiboldPersonChief Executive Officer
May 1, 2016 to presentfactForm ADV
→ Jonathan Lawrence RosenthalPersonManaging Partner, Strategy & Market Intelligence
May 1, 2016 to presentfactForm ADV
→ Arin AragonaPersonManaging Partner, Legal & Operations, Cco
Dec 1, 2016 to Mar 28, 2024inferenceForm ADV
→ Satyavrat Vikas JoshiPersonManaging Partner, Investments
Jun 1, 2017 to Sep 2, 2022inferenceForm ADV

Manages (21)

→ Srg7 LLCFundPrivate Equity Fund
Mar 28, 2024 to presentfactForm ADV
→ Srg5, LLCFundPrivate Equity Fund
May 4, 2023 to presentfactForm ADV
→ Srg6, LLCFundPrivate Equity Fund
May 4, 2023 to presentfactForm ADV
→ Rsf4 II LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Srg4 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Srj1 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Rsf4 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Rsg6 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Srg3 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Rose Capital Fund I LPFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Rsf2 II, LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Rsg2 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Rsg5 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Rsg4 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Rsf2, LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Srg2, LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Rsf5 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Rsg1 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Blueridge Holistics LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Rsf7 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV
→ Srg1 LLCFundPrivate Equity Fund
Mar 31, 2021 to presentfactForm ADV

Dated events

31 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Mar 28, 2024
Person left
Arin Aragona (Managing Partner, Legal & Operations, Cco) no longer on Schedule A of Boldrose Capital
Form ADVobserved 6 days ago
Occurred
Sep 2, 2022
Person left
Satyavrat Vikas Joshi (Managing Partner, Investments) no longer on Schedule A of Boldrose Capital
Form ADVobserved 6 days ago
Occurred
Mar 31, 2021
Adviser first adv filing
Boldrose Capital first filed Form ADV in the extract (IA)
Form ADVobserved 6 days ago

Show 31 bookkeeping events

Occurred
Mar 31, 2026
Boldrose Capital: Private Equity Funds on Form ADV 10 (2024 extract) -> 9 (roster 2026-09-01)
Occurred
Mar 28, 2024
Srg7 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $263,988
Occurred
Mar 28, 2024
Fund 805-5873812409 no longer reported on Form ADV by Boldrose Capital
Occurred
Mar 28, 2024
Fund 805-7053681129 no longer reported on Form ADV by Boldrose Capital
Occurred
Mar 28, 2024
Fund 805-8081474893 no longer reported on Form ADV by Boldrose Capital
Occurred
Mar 28, 2024
Fund 805-8413488248 no longer reported on Form ADV by Boldrose Capital
Occurred
Mar 28, 2024
Fund 805-5221181719 no longer reported on Form ADV by Boldrose Capital
Occurred
Mar 28, 2024
Fund 805-5181319341 no longer reported on Form ADV by Boldrose Capital
Occurred
Mar 28, 2024
Fund 805-7892557098 no longer reported on Form ADV by Boldrose Capital
Occurred
Mar 28, 2024
Fund 805-7659153423 no longer reported on Form ADV by Boldrose Capital
Occurred
May 4, 2023
Srg5, LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $290,856
Occurred
May 4, 2023
Srg6, LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $135,163
Occurred
Mar 30, 2022
Fund 805-8233232949 no longer reported on Form ADV by Boldrose Capital
Occurred
Mar 31, 2021
Srg3 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $1,015,000
Occurred
Mar 31, 2021
Rose Capital Fund I LP first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $70,579,000
Occurred
Mar 31, 2021
Rsf2 II, LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $16,084,000
Occurred
Mar 31, 2021
Rsg2 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $630,000
Occurred
Mar 31, 2021
Rsg5 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $695,000
Occurred
Mar 31, 2021
Rsg4 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $645,000
Occurred
Mar 31, 2021
Rsf2, LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $6,166,000
Occurred
Mar 31, 2021
Srg2, LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $6,210,000
Occurred
Mar 31, 2021
Rsf5 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $5,213,000
Occurred
Mar 31, 2021
Rsg1 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $351,000
Occurred
Mar 31, 2021
Blueridge Holistics LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $250,000
Occurred
Mar 31, 2021
Rsf7 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $645,000
Occurred
Mar 31, 2021
Srg1 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $1,310,000
Occurred
Mar 31, 2021
Srg4 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $397,000
Occurred
Mar 31, 2021
Rsf4 II LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $423,000
Occurred
Mar 31, 2021
Srj1 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $340,000
Occurred
Mar 31, 2021
Rsf4 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $8,730,308
Occurred
Mar 31, 2021
Rsg6 LLC first reported on Form ADV by Boldrose Capital (Private Equity Fund), GAV $3,616,212

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 office address (Form ADV), 1 website (Form ADV), 1 work email (firm website) · as of 2026-09-17

Also named here, with no published line of their own (reach them through the firm): Eileen Kavanagh (Chief Financial Officer), Andrew Todd Schweibold (Chief Executive Officer), Jonathan Lawrence Rosenthal (Managing Partner, Strategy & Market Intelligence).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Private Equity
Canonical id: dfx:pe:0be8f43c-fe9c-4ec5-9260-1384622e3874
First observed: Sep 13, 2026
Last observed: Sep 17, 2026 2 days ago
Source families: Federal regulator filings, Firm and issuer disclosures
3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Boldrose Capital

Private Equity

Greenwich, CT

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:0be8f43c-fe9c-4ec5-9260-1384622e3874

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 20, 2026, 1:02 PM UTC and rebuilt at most every 15 minutes.